Skip to content

Home
Scientific Committee
Agenda
Tracks
Abstract Submission
Registration
Venue
Conference Replay
Abstracts Book
Press Releases
Previous Conferences
Contact

Speakers 2025

Posted on February 7, 2025April 1, 2025 by Targeting Phage Therapy

Share with:

Post navigation

Targeting Phage Therapy News

Practical Session: How to Produce, Manufacture, and Bring Phage Products to Market
Keynote Speech 2025: Prof. Robert T. Schooley
Berlin will Host Targeting Phage Therapy 2025 on June 10-11
Targeting Phage Therapy 2024 Replay
Phage Therapy 2024 Concluding Remarks by Jean-Paul Pirnay: Towards Personalized Phage Therapy

Read more...

Scientific News

Clinical Application of Bacteriophage Therapy in Children
Bacteriophage Therapy: A New Approach for Severe Bacterial Infections
KlebPhaCol: Revealing the Gut’s Hidden Phage Potential in Klebsiella Research
The Hidden Architects of the Gut: Phage-Bacteria Dynamics in Early Childhood Development
Personalized Bacteriophage Therapy: Insights from 100 Consecutive Cases
Exploring the Phageome: Differences in Healthy and Atopic Dermatitis Skin
Untapped Potential: Phage Model Systems as Next-Generation Therapeutic Agents
Armed phages are heading for clinical trials
Vibrio cholerae CBASS System Revolutionizes Antibiotic Sensitivity
Nearly complete structure of bacteriophage DT57C has been revealed

Read more...

Supporters

Newsletters & Press Release

Press Release

Newsletter Archives

Sign up for Newsletter

Follow Us

Linkedin
Facebook

News & Media
Clinical Application of Bacteriophage Therapy in Children
Bacteriophage Therapy: A New Approach for Severe Bacterial Infections
KlebPhaCol: Revealing the Gut’s Hidden Phage Potential in Klebsiella Research
The Hidden Architects of the Gut: Phage-Bacteria Dynamics in Early Childhood Development
Personalized Bacteriophage Therapy: Insights from 100 Consecutive Cases
Exploring the Phageome: Differences in Healthy and Atopic Dermatitis Skin
Untapped Potential: Phage Model Systems as Next-Generation Therapeutic Agents
Armed phages are heading for clinical trials
Vibrio cholerae CBASS System Revolutionizes Antibiotic Sensitivity
Nearly complete structure of bacteriophage DT57C has been revealed

View more

Theme: Vogue by Kaira

Scientific Committee
Abstract Submission
Tracks
Registration
Venue

Scientific News
Newsletters
Press Releases
Contact

Copyright © 2025 - Targeting Phage Therapy

General Sales Conditions | Privacy Policy